UnitedHealth Group (UNH) Stock News, Forecasts and Analysis for Dec. 22, 2025: Independent Reviews, DOJ Scrutiny, and 2026 Guidance in Focus
UnitedHealth Group shares traded near $325.48 on Dec. 22, down slightly from the previous close. The company released initial findings from independent reviews of its Medicare Advantage, care management, and Optum Rx operations, citing broadly sound practices but highlighting areas for improved oversight. UnitedHealth plans to complete most recommended changes by the end of 2025.